Grundinformationen
- Standard-SMILES
Cn1c(=O)[nH]c2ncn(C)c2c1=O- InChIKey
QUNWUDVFRNGTCO-UHFFFAOYSA-N- Summenformel
- C7H8N4O2
- Durchschnittliche Molmasse
- 180,16 g/mol
- Monoisotopische Masse
- 180,06472551
Namen und Bezeichner
- Bevorzugter Name
- Paraxanthine
- IUPAC
- 1,7-dimethyl-3H-purine-2,6-dione
- Lokaler Name
- 3,7-Dihydro-1,7-dimethyl-1H-purin-2,6-dion
- Englischer Name
- 1,7-Dimethylxanthine
- Summenformel
- C7H8N4O2
- Molmasse
- 180.16
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
611-59-6- PubChem CID
- 4687
- DTXSID
DTXSID2052281- ChEMBL
CHEMBL1158- ChEBI
CHEBI:25858- UNII
- Q3565Y41V7
- EC Number
- 210-271-9
- Nikkaji
- J2.991B
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- -0,2
- Polarare Oberfläche (TPSA)
- 67,2 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 0
- Schwere Atome
- 13
- Formalladung
- 0
- Komplexität
- 267
Experimentelle und physikochemische Eigenschaften
Physical Description
Faint yellow fine crystals; [MSDSonline]
Solid
Collision Cross Section
134.2 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: APCI+; Dataset: TOXCAST; Source Identifier: DTXSID2052281];136.8 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID2052281]
149.5 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)];134 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)];138.7 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]
130.85 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];137.69 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];125.98 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];138.86 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
132.4 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
135.63 Ų [M+H]+ [CCS Type: DT; Method: stepped-field]
133.24 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
Physikochemische Eigenschaften
- Schmelzpunkt
- 294 · 294-296 °C (lit.)
- Siedepunkt
- 312.97 °C · 312.97°C (rough estimate)
- Dichte
- 1.364 · 1.3640 (rough estimate)
- Brechungsindex
- 1.67 · 1.6700 (estimate)
- Flammpunkt
- 9 ℃ · 9℃
- storage temp.
- room temp
- Löslichkeit
- 0.6 mg/mL · ethanol: 0.6mg/mL
- Aggregatzustand
- solid
- pka
- 8.5 · pKa 8.5 (Uncertain)
- Farbe
- white
- BRN
- 197907 · 197907
- Stabilität
- Store tightly sealed at RT
- Kosmetik-Inhaltsstoffe Funktionen
- SKIN CONDITIONING
- InChI
- InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)11(2)7(13)9-5/h3H,1-2H3,(H,9,13)
- InChIKey
- QUNWUDVFRNGTCO-UHFFFAOYSA-N
- SMILES
- N1(C)C2=C(NC(=O)N(C)C2=O)N=C1
- EPA chemische Informationen
- 1 H-Purine-2,6-dione, · 1H-Purine-2,6-dione, 3,7-dihydro-1,7-dimethyl- (611-59-6)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
This chemical does not meet GHS hazard criteria for 6.7% (3 of 45) of reports.
Warning
H302 (93.3%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 45 reports by companies from 3 notifications to the ECHA C&L Inventory.;Reported as not meeting GHS hazard criteria per 3 of 45 reports by companies.;There are 2 notifications provided by 42 of 45 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Gefahrenhinweise
Toxikologische Informationen
USGS Health-Based Screening Levels for Evaluating Water-Quality
1,7-Dimethylxanthine
Pharmaceutical
Smith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP
Sicherheitsdaten
- wgk
- 3
- ridadr
- UN1230 - class 3 - PG 2 - Methanol, solution
- hs_code
- 2933.59.9500
- RTECS-Nr.
- RV9380000
- risk_code
- 22-39/23/24/25-23/24/25-11
- Toxizität
- mmo-esc 150 mg/L CSHSAZ 16,337,52
- hazard_code
- Xn,T,F
- safety_code
- 22-24/25-45-36/37-16-7
- Speicherklasse
- 11 - Combustible Solids
- Hazard Classifications
- Acute Tox. 4 Oral
Chemie und Industrie
Pharmakologische Informationen
Verwendung und Herstellung
Anwendungen
BeschreibungParaxanthine is an inhibitor of phosphodiesterase 9 (PDE9) and an antagonist of adenosine receptors A1 and A2 (Kis = 35 and 22 μM, respectively in equine forebrain tissues). It is the main metabolite of caffeine in humans, making up 80% of the three dimethylxanthine metabolites produced by caffeine demethylation. Paraxanthine increases locomotor activity and counteracts adenosine receptor agonist-induced motor depression in rats not habituated to caffeine. At a dose of 30 mg/kg, paraxanthine induces a significant increase in striatal cGMP and extracellular striatal dopamine concentrations in vivo. It also promotes wakefulness and increases locomotor activity and core temperature in narcoleptic transgenic mice without increasing behavioral anxiety.
Verwenden1,7-Dimethylxanthine has been used for the quantification of caffeine by high-performance liquid chromatography (HPLC).
Vor- und nachgelagerte Produkte
Nachgelagerte Produkte
Anbieter50 Anbieter
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…